Literature DB >> 34043455

Optimizing Risk Stratification in Acute Myeloid Leukemia: Dynamic Models for a Dynamic Therapeutic Landscape.

Nicholas J Short1, Martin S Tallman2, Daniel A Pollyea3, Farhad Ravandi1, Hagop Kantarjian1.   

Abstract

Entities:  

Year:  2021        PMID： 34043455     DOI： 10.1200/JCO.21.00067

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Is allogeneic transplantation the preferred therapy for older patients with acute myeloid leukemia?

Authors:  Arnold Ganser
Journal:  Haematologica       Date:  2022-07-01       Impact factor: 11.047

2.  Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements.

Authors:  Ghayas C Issa; Jabra Zarka; Koji Sasaki; Wei Qiao; Daewoo Pak; Jing Ning; Nicholas J Short; Fadi Haddad; Zhenya Tang; Keyur P Patel; Branko Cuglievan; Naval Daver; Courtney D DiNardo; Elias Jabbour; Tapan Kadia; Gautam Borthakur; Guillermo Garcia-Manero; Marina Konopleva; Michael Andreeff; Hagop M Kantarjian; Farhad Ravandi
Journal:  Blood Cancer J       Date:  2021-09-29       Impact factor: 11.037

3.  Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantation.

Authors:  H Joachim Deeg
Journal:  Blood Adv       Date:  2022-03-08

4.  Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation.

Authors:  Siok-Keen Tey; Steven W Lane
Journal:  Blood Adv       Date:  2022-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.